A new laser crystal from Lu2.4Y0.6Al5O12 (LuYAG) co-doped with Cr3+, Tm3+, Ho3+, and Pr3+ ions was grown successfully by the Czochralski method for the first time. The structure parameters of the Cr,Tm,Ho,Pr:LuYAG crystal are determined by the X-ray Rietveld refinement method. The main absorption bands are observed near 426 and 782 nm, and the fluorescence spectrum excited by a 450 nm or 783 nm LD presents an emission band near 2.911 μm, indicating that the co-doped Cr3+ and Tm3+ ions can be utilized as sensitizers for the Ho3+ ions. The lifetimes of the 5I6 and 5I7 levels of the Ho3+ ions were measured and fitted to be 0.070 ms and 1.852 ms, respectively. The energy transfer efficiencies of the processes 5I6 (Ho3+) → 3F3,4 (Pr3+) and 5I7 (Ho3+) → 3F2 (Pr3+) + 3H6 (Pr3+) were calculated, showing that the Pr3+ ions can play the role of a deactivator for the Ho3+ ions. Furthermore, the energy transfer mechanisms among the Cr3+, Tm3+, Ho3+, and Pr3+ ions were studied. The results suggest that the Cr,Tm,Ho,Pr:LuYAG crystal is a new promising laser medium operating at around 2.9 μm under flash lamp or 783 nm LD pumping.
No takes yet. Share an insight, caveat, or question.
Zhang et al. (2016) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: